Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

NCT02735603 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Repolarization

Interventions

DRUG: Naltrexone HCl/bupropion HCl
OTHER: Placebo
DRUG: Moxifloxacin

Sponsor

Orexigen Therapeutics, Inc